Online search for clinical trials now available in German

August 29, 2013 – 01:54
Drexel pot study will test gateway theory of young adult drug

The International Pharmaceutical Federation IFPMA represents patients, doctors, pharmacists and other interested parties since today's Internet search engine for clinical trials in German ready. Launched in English in the fall of 2005, the site offers two different ways to search for clinical trials to test medications:

  • Ongoing clinical trials

    The information on ongoing clinical trials in addition to information on the study drug and its indication and contact information for doctors and patients, if they wish to participate in the study.

  • Results of completed studies

    The information on completed studies in addition to information on the drug and its indication, a summary of the study results.

The portal is related to the commitment of the research-based pharmaceutical companies, according to clinical trial information should be accessible to everyone. The drug company had committed itself to register ongoing trials and beyond to publish the results of studies, which are available to authorized medicinal products. As appropriate publications partially present in different databases and different Internet servers, the IFPMA has now created with the portal a convenient solution that scans all systems simultaneously and provides the user with a common search result.

When searching is also possible to search within a particular country ongoing studies.

The search functions are available immediately, except in German, in French, Spanish and Japanese. However, results are (mostly English) issued in the original recorded language.

The VFA has published on its website for some time, in which databases its member companies clinical trials and publish test results (see: ).

Search IFPMA Clinical Trials Portal:

Source: www.vfa.de

Finding the Evidence: A Gateway to the Literature in Child and Adolescent Mental Health
Book (Amer Psychiatric Pub)

OT Toxic Psychiatry

2012-12-13 22:22:18 by Masters_apprentice

As Dr. Peter Breggin describes it in his landmark book, Toxic Psychiatry, a deal was struck. Drug companies would bankroll psychiatry and rescue it. These companies would pour money into professional conferences, journals, research. In return, they wanted “science” that would promote mental disease as a biological fact, a gateway into the drugs. Everyone would win—except the patient.
So the studies were rolled out, and the list of mental disorders expanded. The FDA was in on the deal as well, as evidenced by their drug approvals, in the face of the obvious damage these drugs were doing

You might also like:

Savages - Ben and Chon find out O has been kidnapped
Savages - Ben and Chon find out O has been kidnapped

Foreign companies stop clinical trials in India after government amends rules ..  — Times of India
Patients who participate in a clinical trial receive greater degree of medical care than they would have under regular treatment because of the high level of investigations and patient management that a clinical study protocol requires,'' Thatte said ..

IOS Press HealthGrid Applications and Technologies Meet Science Gateways for Life Sciences (Studies in Health Technology and Informatics)
Book (IOS Press)

Related posts:

  1. ICON Medical Research Study
  2. Find Medical research studies
  3. UVA Medical research Studies